Prot #CVL‐231‐2003: A 52‐week, Phase 2, Open‐label Trial to Evaluate the Long‐term Safety and Tolerability of CVL‐231 in Adult Participants With Schizophrenia

Project: Research project

Project Details

StatusActive
Effective start/end date6/8/23 → 6/8/26

Funding

  • PPD Investigator Services, LLC (Prot #CVL-231-2003 // Prot #CVL-231-2003)
  • Cerevel Therapeutics, LLC (Prot #CVL-231-2003 // Prot #CVL-231-2003)